ApoCell is Drug Discovery in United States that focus on economical diagnostic options business. Founded in 2004. They cover business area such as developer, molecular biomarker detection, analysis service, biomarker signature, clinical trial subject, tumor cell, CTCs, label, antibody, whole blood, invasive tumor biopsy, patient, more economical diagnostic option, its technology, prostate, lung, breast, colon, liver, cancer.
2004
( 20 years old in 2024 )
Economical Diagnostic Options
-
2575 West Bellfort Street
Suite 190
Houston, TX 77054
United States
Private
developermolecular biomarker detectionanalysis servicebiomarker signatureclinical trial subjecttumor cellCTCslabelantibodywhole bloodinvasive tumor biopsypatientmore economical diagnostic optionits technologyprostatelungbreastcolonlivercancer
* We use standard office opening hours in near ApoCell's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ApoCell is Drug Discovery business from United States that founded in 2004 (20 years old in 2024), ApoCell business is focusing on Economical Diagnostic Options.
ApoCell headquarter office and corporate office address is located in 2575 West Bellfort Street Suite 190 Houston, TX 77054 United States.
ApoCell was founded in United States.
In 2024, ApoCell is currently focus on economical diagnostic options sector.
Above is snippet of Google Trends for "economical diagnostic options" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ApoCell, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
